BRCA-MUTATED OVARIAN CARCINOMA
Clinical trials for BRCA-MUTATED OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BRCA-MUTATED OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for BRCA-MUTATED OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in shrinking ovarian tumors before surgery
Disease control OngoingThis early trial is testing whether the drug olaparib can shrink tumors in people with newly diagnosed BRCA-mutant ovarian, fallopian tube, or peritoneal cancer before they have surgery. Fifteen participants will receive olaparib for two cycles, then undergo standard chemotherapy…
Matched conditions: BRCA-MUTATED OVARIAN CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Family genetic testing could prevent ovarian cancer
Knowledge-focused OngoingThis study looks at whether offering genetic testing to family members of people with hereditary breast and ovarian cancer syndrome helps more relatives learn about their own cancer risk. Researchers will follow 118 participants and their relatives to see how many choose to get t…
Matched conditions: BRCA-MUTATED OVARIAN CARCINOMA
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC